| Literature DB >> 32423061 |
Carlos David Grande Tovar1, Jorge Iván Castro2, Carlos Humberto Valencia3, Paula A Zapata4, Moisés A Solano1, Edwin Florez López5, Manuel N Chaur2,6, Mayra Eliana Valencia Zapata7, José Herminsul Mina Hernandez7.
Abstract
Scaffold development for cell regeneration has increased in recent years due to the high demand for more efficient and biocompatible materials.Entities:
Keywords: chitosan beads; graphene-oxide; nanocomposites; tissue engineering; titanium dioxide nanoparticles
Mesh:
Substances:
Year: 2020 PMID: 32423061 PMCID: PMC7287625 DOI: 10.3390/molecules25102308
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Characterization of TiO2 nanoparticles by (A) TEM, (B) XRD, and (C) FTIR spectroscopy.
Figure 2Characterization of GO by (A) Raman spectroscopy, (B) XRD, and (C) atomic force microscopy (AFM).
Figure 3FTIR images of the different nanocomposite beads of CS-GLA, CS-GO-GLA, CS-TiO2-GLA, and CS-TiO2-GO-GLA).
Figure 4X-ray diffraction (DRX) of the different nanocomposite beads: (A) CS-GLA, (B) CS-GO-GLA, (C) CS-TiO2-GLA, and (D) CS-TiO2-GO-GLA.
The crystallinity index (Xc) of the different formulations calculated from the XRD analysis.
| Formulation | Xc (%) |
|---|---|
| CS-GLA | 10.8 |
| CS-GO-GLA | 15.5 |
| CS-TiO2-GLA | 24.0 |
| CS-TiO2-GO-GLA | 21.8 |
Figure 5SEM images. Morphology of the beads: CS-GLA (A) at 100×, (B) at 1000×, (C) at 25,000×; CS-GO-GLA (D) at 100×, (E) at 1000×, (F) at 25000×; CS-TiO2-GLA (G) at 100×, (H) at 1000×, (I) at 25,000×; CS-TiO2-GO-GLA (J) at 100×, (K) at 1000×, (L) at 25,000×.
Figure 6Images of the different bead composites: (A) CS-GLA, (B) CS-GO-GLA, (C) CS-TiO2-GLA, (D) CS-GO-TiO2-GLA.
Td3% of the nanocomposite beads (CS-GLA, CS-GO-GLA, CS-TiO2-GLA, and CS-TiO2-GO-GLA).
| Sample | Td3% (°C) |
|---|---|
| CS-GLA | 92.8 |
| CS-GO-GLA | 131.3 |
| CS-TiO2-GLA | 85.8 |
| CS-TiO2-GO-GLA | 124.7 |
| CS pure | 44.2 |
Td3%: decomposition temperature at 3% weight loss, Tg: glass transition temperature.
Figure 7HR-TEM images of the different beads: CS-GO-GLA (A) 1000 nm, (B) 500 nm, (C) 200 nm, (D) 100 nm; CS-GO-TiO2-GLA (E) 1000 nm, (F) 500 nm, (G) 200 nm, (H) 100 nm; CS-TiO2-GLA (I) 1000 nm (J) 500 nm (K) 200 nm, (L) 100 nm.
Figure 8Zone of subdermal implantation in Wistar rats after 30, 60, and 90 days (A) Hair recovery, (B) Absence of immune responses, (C) Subdermal implantation zones with samples encapsulated by scar tissue. B: Beads. IZ: Implantation zone.
Figure 9Beads implanted in subdermal tissue. (A,B): CS-GO-TiO2-GLA. (C,D): CS-TiO2-GLA. (E,F): CS-TiO2-GLA. (A,C,E): Hematoxylin and eosin stain technique at 4×. (B,D,F): SEM technique. B: Bead. P: Pore. Fc: Fibrous capsule. Fm: Fibrous membrane. C: Cell.
Figure 10Beads embedded in subdermal tissue. (A,B): CS-GO-GLA. (C,D): CS-GO-TiO2-GLA. (A,C): Hematoxylin and eosin (H-E) stain technique to 4×. (B,D): SEM technique. B: Bead. P: Pore. Fc: Fibrous capsule. Fm: Fibrous membrane.
Figure 11Beads implanted in subdermal tissue. (A) CS-TiO2-GLA. (B) CS-GO-TiO2-GLA. SEM-EDS technique.
Figure 12Beads implanted in subdermal tissue. (A) CS-GO-GLA. (B) CS-TiO2- GLA. (C) CS-GO-GLA. (D) CS-GO-TiO2-GLA. (A) at 4×. (B), (C), and (D) at 10×. E: Epidermis. D: Dermis. M: Muscle. B: Bead. Fc: Fibrous capsule. COL - Fb: Type I collagen fiber. Masson′s trichrome stain (MT) technique.
Figure 13Beads implanted in subdermal tissue. (A) CS-GO-TiO2-GLA. (B) CS-TiO2- GLA. (C,D) CS-GLA. (E) CS-GO-GLA. (F) CS-GO-TiO2-GLA. II: Inflammatory infiltrate. Fm. Fibrous membrane. Fc: Fibrous capsule. B: Bead. Mf: Macrophages. 10× images. Masson′s trichrome stain (MT) technique.